Triad Vascular Systems Inc.
This article was originally published in Start Up
Executive Summary
Triad Vascular Systems is using advanced simulation tools to design a percutaneous AAA device.
You may also be interested in...
Staying the Course in Endovascular AAA Repair
The legal troubles and withdrawal of Guidant from the endovascular abdominal arotic aneurysm repair market may have cast a pall on public perception of the procedure, but competitors advancing new devices towards the market believe it just means a bigger piece of the pie for everyone.
NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
Warning Letter Roundup & Recap – 19 January 2021
No device-related warning letters were released by the US FDA the week of 19 January.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: